SELUMETINIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where SELUMETINIB was used for Neoplasm.
Most Reported Side Effects for SELUMETINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Blood creatine phosphokinase increased | 105 | 9.0% | 1 | 7 |
| Rash | 89 | 7.6% | 0 | 13 |
| Off label use | 78 | 6.7% | 4 | 6 |
| Paronychia | 73 | 6.2% | 1 | 8 |
| Dermatitis acneiform | 61 | 5.2% | 1 | 5 |
| Diarrhoea | 59 | 5.0% | 1 | 13 |
| Fatigue | 54 | 4.6% | 1 | 9 |
| Acne | 52 | 4.4% | 0 | 5 |
| Nausea | 49 | 4.2% | 0 | 15 |
| Death | 47 | 4.0% | 47 | 0 |
| Alopecia | 45 | 3.8% | 0 | 9 |
| Vomiting | 40 | 3.4% | 1 | 11 |
| Abdominal pain | 35 | 3.0% | 0 | 5 |
| Headache | 33 | 2.8% | 1 | 9 |
| Pruritus | 31 | 2.7% | 0 | 2 |
Other Indications for SELUMETINIB
Neurofibromatosis (499)
Neurofibroma (192)
Brain neoplasm malignant (37)
Nervous system neoplasm benign (18)
Glioma (17)
Neoplasm malignant (15)
Non-small cell lung cancer (14)
Optic glioma (8)
Brain neoplasm (6)
Acute lymphocytic leukaemia (5)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)